Relationship between the duration of ischemia and final infarct size in STEMI patients treated with abciximab and primary PCI

被引：0
|
作者：
Tim Tödt
Eva Maret
Joakim Alfredsson
Magnus Janzon
Jan E Engvall
Eva E Swahn
机构：
[1] Linköping University,Department of Medical and Health Sciences, Division of Cardiology
[2] Linköping University,Center for Medical Image Science and Visualization
[3] Ryhov County Hospital,Department of Clinical Physiology
[4] Linköping University,Department of Clinical Physiology UHL
来源：
Journal of Cardiovascular Magnetic Resonance | / 14卷 / Suppl 1期
关键词：
Percutaneous Coronary Intervention; Infarct Size; Symptom Onset; Abciximab; Ischemic Time;
D O I：
10.1186/1532-429X-14-S1-P21
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Upstream clopidogrel treatment - impact on infarct size and microvascular obstruction assessed by CMR in patients with STEMI undergoing primary PCI
    De Waha, S.
    Eitel, I.
    Desch, S.
    Fuernau, G.
    Lurz, P.
    Schuler, G.
    Thiele, H.
    EUROPEAN HEART JOURNAL, 2012, 33 : 473 - 473
  • [22] EFFECT OF UPSTREAM CLOPIDOGREL TREATMENT ON INFARCT SIZE AND MICROVASCULAR OBSTRUCTION ASSESSED BY CMR IN PATIENTS WITH STEMI UNDERGOING PRIMARY PCI
    de Waha, Suzanne
    Eitel, Ingo
    Desch, Steffen
    Fuernau, Georg
    Lurz, Philipp
    Schuler, Gerhard
    Thiele, Holger
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E345 - E345
  • [23] Smoking and infarct size among STEMI patients undergoing primary angioplasty
    De Luca, Giuseppe
    Parodi, Guido
    Sciagra, Roberto
    Bellandi, Benedetta
    Comito, Vincenzo
    Vergara, Ruben
    Migliorini, Angela
    Valenti, Renato
    Antoniucci, David
    ATHEROSCLEROSIS, 2014, 233 (01) : 145 - 148
  • [24] No association between CKD and TVR in patients with STEMI treated by PCI
    Yang, W.
    Idris, H.
    Burgess, S.
    Mussap, C.
    Juergens, C. J.
    Hee, L.
    Kadappu, K.
    Nguyen, T.
    Thomas, L.
    French, J. K.
    EUROPEAN HEART JOURNAL, 2016, 37 : 966 - 966
  • [25] EARLY ANTIPLATELET THERAPY UPGRADE IN STEMI PATIENTS TREATED WITH PRIMARY PCI
    Lupi, A.
    Lazzero, M.
    Rognoni, A.
    Cavallino, C.
    Bongo, A. S.
    CARDIOLOGY, 2016, 134 : 47 - 47
  • [26] Early antiplatelet therapy upgrade in STEMI patients treated with primary PCI
    Lupi, A.
    Rognoni, A.
    Rossi, L.
    Cavallino, C.
    Rosso, R.
    Lazzero, M.
    Bongo, A. S.
    Porto, I.
    EUROPEAN HEART JOURNAL, 2016, 37 : 1384 - 1384
  • [27] Bundle branch blocks and outcomes in STEMI patients treated with primary PCI
    Har, B.
    Galbraith, P. D.
    Southern, D.
    Zhang, M.
    Bizios, A.
    Knudtson, M. L.
    EUROPEAN HEART JOURNAL, 2014, 35 : 971 - 971
  • [28] IMPACT OF MORPHINE USE ON MORTALITY IN STEMI PATIENTS TREATED WITH PRIMARY PCI
    Hizoh, Istvan
    Domokos, Dominika
    Banhegyi, Gyongyver
    Major, Laszlo
    Edes, Istvan Ferenc
    Becker, David
    Ruzsa, Zoltan
    Merkely, Bela
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 70 - 70
  • [29] Sex-related differences in STEMI patients treated by primary PCI
    Barthelemy, O.
    Degrell, P.
    Petroni, T.
    Silvain, J.
    Choussat, R.
    Collet, J. P.
    Helft, G.
    Michel, P. L.
    Montalescot, G.
    Le Feuvre, C.
    EUROPEAN HEART JOURNAL, 2013, 34 : 237 - 237
  • [30] The obesity paradox in STEMI patients treated with primary PCI: is it a matter of sex?
    Somaschini, A.
    Crimi, G.
    Cornara, S.
    Buratti, S.
    Ferlini, M.
    Camporotondo, R.
    Gnecchi, M.
    Bartolini, D.
    Belotti, S.
    Fedele, M.
    Iannone, A.
    Beccaria, F.
    Visconti, L. Oltrona
    Rubartelli, P.
    De Ferrari, G. M.
    EUROPEAN HEART JOURNAL, 2018, 39 : 1346 - 1347
12345